Connecting Global Leaders, Start-ups and Investors to Shape the Future of Healthcare
MIXiii 2026, Israel’s flagship health-tech and life sciences conference and exhibition, will take place on 17th–18th March 2026 at the ICC, Jerusalem, bringing together a distinguished community of industry leaders, researchers, entrepreneurs, start-ups, investors, venture capital funds and senior decision-makers from across the global innovation ecosystem.
Led and organised by the Israel Advanced Technology Industries Association, MIXiii serves as the central annual platform for collaboration, knowledge exchange and business development within Israel’s rapidly growing life sciences and health-tech sector. The conference plays a vital role in strengthening Israel’s position as a global hub for technological innovation while contributing meaningfully to the advancement of healthcare solutions worldwide.
The two-day programme has been carefully designed to reflect the most relevant and future-oriented themes in healthcare innovation. Participants will benefit from a rich agenda comprising high-level plenary sessions, expert keynote lectures and multiple parallel thematic tracks. Core focus areas include emergency medicine, TechBio, MedTech, healthcare venture building, emerging technologies from Israeli academia, innovation in ophthalmology, and a highly anticipated digital health start-up competition.
The opening day will highlight institutional and venture investor perspectives on Israeli health-tech, industry-led discussions on artificial intelligence in healthcare, and technology showcases by innovative start-ups. Dedicated sessions will bring together entrepreneurs and venture capital leaders, fostering direct dialogue and partnership opportunities. A special focus will also be placed on ophthalmology innovation and MedTech commercialisation pathways, offering valuable insight into market access and clinical translation.
The second day will focus strongly on healthcare resilience, Tech-Bio innovation and advanced clinical technologies. Plenary discussions will explore artificial intelligence in biology, healthcare preparedness in times of crisis, regulatory developments and international venture capital trends. Participants will also be able to join specialised parallel tracks such as emergency management and preparedness programmes, technology transfer pitching sessions, hospital-at-home innovation models, and next-generation biomedical and health innovation initiatives.
In addition to the extensive knowledge programme, delegates will enjoy access to the dedicated MIXiii B2B networking platform, enabling curated business meetings and strategic matchmaking across the global health-tech ecosystem. An exclusive surprise evening show on 17th March will further enrich the conference experience and create an informal setting for professional networking.
MIXiii 2026 stands as Israel’s most influential gathering for the life sciences and health-tech community, serving as a catalyst for international partnerships, investment activity and collaborative innovation—shaping the future of healthcare in Israel and beyond.